Page last updated: 2024-11-08

carbon tetrachloride and Hepatopulmonary Syndrome

carbon tetrachloride has been researched along with Hepatopulmonary Syndrome in 1 studies

Carbon Tetrachloride: A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)
tetrachloromethane : A chlorocarbon that is methane in which all the hydrogens have been replaced by chloro groups.

Hepatopulmonary Syndrome: A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, Z1
Qi, X1
Li, Z1
Xu, L1
Wang, F1
Wang, S1
Chang, Y1
Ma, W1
Xu, M1
Yang, C1

Other Studies

1 other study available for carbon tetrachloride and Hepatopulmonary Syndrome

ArticleYear
Hepatopulmonary syndrome: the role of intra-abdominal hypertension and a novel mouse model.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:2

    Topics: Albumins; Alkalosis, Respiratory; Animals; Blood Gas Analysis; Carbon Tetrachloride; Hepatopulmonary

2014